For instance, high levels of sPD-L1 were also observed in patients diagnosed with metastatic clear-cell renal-cell carcinoma compared to those with non-metastatic disease [24], and sPD-L1 levels were significantly elevated in patients with muscle-invasive and metastatic bladder cancer [25]. This evidence concerns the gene SPDL1 and metastatic neoplasm.